全球银屑病关节炎治疗市场研究报告 - 2023-2030 年行业分析、规模、份额、增长、趋势和预测

全球对银屑病关节炎治疗药物的需求估计将从 2022 年的 15.24 美元增长到 2030 年的约 38,390 亿美元，在 2023-2030 年调查期间的复合年增长率为 12.24%。

银屑病关节炎药物可治疗银屑病关节炎，一种影响某些银屑病患者的关节炎，是一种称为银屑病的皮肤病，会产生覆盖着银色鳞屑的红色皮肤区域。. 一般来说，关节炎通常是在牛皮癣出现后才被诊断出来的。 然而，有时关节问题先于皮疹。 当免疫系统开始针对健康细胞和组织时，就会出现这种情况。 关节炎症和皮肤细胞的过度生成是由不适当的免疫反应引起的。

市场动态：

随着关节炎患者数量的增加，关节炎治疗药物的市场可能会扩大。 不健康的生活方式，如过度饮酒和吸烟，也被认为是发展银屑病关节炎的危险因素，这可能会扩大银屑病关节炎治疗药物的市场。 肥胖是推动银屑病关节炎发展的主要因素之一，可能会增加治疗药物的市场增长。 此外，创新疗法的发现预计将推动银屑病关节炎疗法市场的发展。 高昂的治疗成本、严格的监管批准和药物副作用等因素可能会阻碍银屑病关节炎治疗市场的增长。

这份研究报告描述了波特的五力模型、市场吸引力分析和价值链分析。 这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。 此外，这些工具还提供了对全球银屑病关节炎治疗市场各个部分的全面评估。 银屑病关节炎治疗行业的发展和趋势为这项研究提供了一种整体方法。

市场细分：

本节提供有关银屑病关节炎治疗市场报告的国家和地区细分的详细数据，从而帮助策略师确定其各自产品或服务的目标人群以及未来的机会。帮助您获得

按药物类别

• 肿瘤坏死因子抑製剂
• 白细胞介素抑製剂
• Pde4 抑製剂
• 其他

按给药途径

• 口语
• 肠外
• 专题

按分销渠道

• 医院药房
• 零售药房
• 在线药店

按地区分析：

本节涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲对银屑病关节炎治疗药物市场的当前和未来需求。 此外，它还关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 银屑病关节炎药物市场的主要参与者是 AbbVie Inc.、Janssen Pharmaceutical NV、Novartis AG、Amgen Inc.、Celgene Corporation、Eli Lilly and Company、Bristol Myers Squibb、UCB S.A. 主要併购、竞争格局的整体视图，包括各种战略发展，例如未来能力、合作伙伴关係、财务概况、联盟、新产品开发、新产品发布和其他发展。

内容

第一章前言

• 报告内容
  • 目的
  • 目标受众
  • USP（独特的销售建议）及其提供的内容
• 调查范围
• 调查方法
  • 市场调研流程
  • 市场研究方法

第 2 章执行摘要

• 市场亮点
• 全球市场概况

第 3 章银屑病关节炎药物 - 行业分析

• 简介 - 市场动态
• 市场驱动力
• 市场製约因素
• 机会
• 行业趋势
• 波特的五力分析
• 市场吸引力分析
  • 按药物类别进行的市场吸引力分析
  • 按给药途径进行的市场吸引力分析
  • 按分销渠道进行的市场吸引力分析
  • 市场吸引力分析：按地区

第四章价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原材料製造商名单
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直接营销
  • 间接营销
  • 市场发展趋势

第 5 章 COVID-19 爆发的影响分析

第 6 章全球银屑病关节炎药物市场分析：按药物类别分类

• 按药物类别汇总
• 过去和未来的数据
• 按药物类别分析
• 肿瘤坏死因子抑製剂
• 白细胞介素抑製剂
• PDE4抑製剂
• 其他

第 7 章银屑病关节炎药物给药途径的全球市场分析

• 按给药途径汇总
• 过去和未来的数据
• 给药途径分析
• 口语
• 肠外
• 专题

第 8 章银屑病关节炎药物分销渠道的全球市场销售分析

• 按分销渠道概述
• 过去和未来的数据
• 按分销渠道分析
• 医院药房
• 零售药房
• 在线药店

第9章按地区分列的银屑病关节炎药物的全球市场销售分析

• 按地区进行的销售前景分析
• 介绍销售分析
• 北美销售分析
  • 概览、历史和预测销售分析
  • 北美各部门的销售分析
  • 北美销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史和预测销售分析
  • 按细分市场进行的欧洲销售分析
  • 按国家/地区划分的欧洲销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 其他欧洲销售分析
• 亚太地区销售分析
  • 概览、历史和预测销售分析
  • 亚太地区各部门的销售分析
  • 亚太国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本的销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 其他亚太地区销售分析
• 拉丁美洲销售分析
  • 概览、历史和预测销售分析
  • 拉丁美洲各部门的销售分析
  • 拉丁美洲国家/地区的销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利的销售分析
  • 其他拉丁美洲销售分析
• 中东和非洲销售分析
  • 概览、历史和预测销售分析
  • 中东和非洲各细分市场的销售额分析
  • 中东和非洲国家/地区的销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 其他中东和非洲销售分析

第10章：银屑病关节炎药物公司的竞争格局

• 银屑病关节炎药物市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他扩展

第11章公司简介

• 前 10 名公司的市场份额分析
• 市场集中度
• 艾伯维公司
  • 公司简介
  • 企业收入
  • 产品介绍
  • 近期趋势
• 杨森製药公司
  • 公司简介
  • 企业收入
  • 产品介绍
  • 近期趋势
• 诺华公司
  • 公司简介
  • 企业收入
  • 产品介绍
  • 近期趋势
• 安进公司
  • 公司简介
  • 企业收入
  • 产品介绍
  • 近期趋势
• 新基公司
  • 公司简介
  • 企业收入
  • 产品介绍
  • 近期趋势
• 礼来公司
  • 公司简介
  • 企业收入
  • 产品介绍
  • 近期趋势
• 百时美施贵宝
  • 公司简介
  • 企业收入
  • 产品介绍
  • 近期趋势
• UCB S.A.
  • 公司简介
  • 企业收入
  • 产品介绍
  • 近期趋势

注意：在公司简介、财务细节、近期发展等方面，基于可用信息，私人控股公司可能不包括在内。

The global demand for Psoriatic Arthritis Therapeutics Market is presumed to reach the market size of nearly USD 38.39 BN by 2030 from USD 15.24 BN in 2022 with a CAGR of 12.24% under the study period 2023 - 2030.

Psoriatic arthritis therapeutics to treat psoriatic arthritis, a kind of arthritis that affects certain psoriasis patients, is a skin condition known as psoriasis that creates red regions of skin coated in silvery scales. Typically, psoriatic arthritis is not diagnosed until after psoriasis has developed in a patient. Occasionally, though, joint problems may develop before skin rashes. This condition manifests when the immune system starts targeting healthy cells and tissue. Joint inflammation and excessive skin cell creation result from an inappropriate immunological response.

Market Dynamics:

The rising incidence of psoriatic arthritis patients may boost the market for psoriatic arthritis therapeutics. Factors such as an unhealthy lifestyle with excessive alcohol use and smoking can also be recognized as risk factors for developing psoriatic arthritis, hence growing the market for psoriatic arthritis therapeutics. Obesity is one of the primary factors that might accelerate the incidence of psoriatic arthritis, therefore expanding the market growth of treatment. Furthermore, the discovery of innovative therapy approaches is projected to propel the psoriatic arthritis therapeutics market forward. Factors such as high treatment costs, demanding regulatory approval, and drug side effects may impede the growth of the Psoriatic arthritis therapeutics market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of psoriatic arthritis therapeutics. The growth and trends of psoriatic arthritis therapeutics industry provide a holistic approach to this study.

Market Segmentation:

This section of the psoriatic arthritis therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

• TNF Inhibitors
• Interleukin Inhibitors
• Pde4 Inhibitors
• Others

By Route Of Administration

• Oral
• Parenteral
• Topical

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Psoriatic Arthritis Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the psoriatic arthritis therapeutics market include AbbVie Inc., Janssen Pharmaceutical NV, Novartis AG, Amgen Inc., Celgene Corporation, Eli Lilly and Company, Bristol Myers Squibb, UCB S.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . PSORIATIC ARTHRITIS THERAPEUTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Drug Class
  • 3.7.2 Market Attractiveness Analysis By Route Of Administration
  • 3.7.3 Market Attractiveness Analysis By Distribution Channel
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PSORIATIC ARTHRITIS THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

• 6.1 Overview by Drug Class
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Drug Class
• 6.4 TNF Inhibitors Historic and Forecast Sales by Regions
• 6.5 Interleukin Inhibitors Historic and Forecast Sales by Regions
• 6.6 PDE4 Inhibitors Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL PSORIATIC ARTHRITIS THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 7.1 Overview by Route Of Administration
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Route Of Administration
• 7.4 Oral Historic and Forecast Sales by Regions
• 7.5 Parenteral Historic and Forecast Sales by Regions
• 7.6 Topical Historic and Forecast Sales by Regions

8 . GLOBAL PSORIATIC ARTHRITIS THERAPEUTICS MARKET SALES ANALYSIS BY DISTRIBUTION CHANNEL

• 8.1 Overview by Distribution Channel
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Distribution Channel
• 8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
• 8.5 Retail Pharmacies Historic and Forecast Sales by Regions
• 8.6 Online Pharmacies Historic and Forecast Sales by Regions

9 . GLOBAL PSORIATIC ARTHRITIS THERAPEUTICS MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE PSORIATIC ARTHRITIS THERAPEUTICS COMPANIES

• 10.1. Psoriatic Arthritis Therapeutics Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF PSORIATIC ARTHRITIS THERAPEUTICS INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. AbbVie Inc.
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Janssen Pharmaceutical NV
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Novartis AG
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Amgen Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Celgene Corporation
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Eli Lilly and Company
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Bristol Myers Squibb
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. UCB S.A
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Drug Class (USD MN)
• TNF Inhibitors Market Sales by Geography (USD MN)
• Interleukin Inhibitors Market Sales by Geography (USD MN)
• PDE4 Inhibitors Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Route Of Administration (USD MN)
• Oral Market Sales by Geography (USD MN)
• Parenteral Market Sales by Geography (USD MN)
• Topical Market Sales by Geography (USD MN)
• Analysis by Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales by Geography (USD MN)
• Retail Pharmacies Market Sales by Geography (USD MN)
• Online Pharmacies Market Sales by Geography (USD MN)
• Global Psoriatic Arthritis Therapeutics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Psoriatic Arthritis Therapeutics Report
• Market Research Process
• Market Research Methodology
• Global Psoriatic Arthritis Therapeutics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Drug Class
• Market Attractiveness Analysis by Route Of Administration
• Market Attractiveness Analysis by Distribution Channel
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Drug Class (USD MN)
• TNF Inhibitors Market Sales by Geography (USD MN)
• Interleukin Inhibitors Market Sales by Geography (USD MN)
• PDE4 Inhibitors Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Route Of Administration (USD MN)
• Oral Market Sales by Geography (USD MN)
• Parenteral Market Sales by Geography (USD MN)
• Topical Market Sales by Geography (USD MN)
• Global Market Analysis by Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales by Geography (USD MN)
• Retail Pharmacies Market Sales by Geography (USD MN)
• Online Pharmacies Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.